Enterprise Evidence Report · NR-REPORT-V2.0

United Kingdom
Neuroscience Intelligence

United Kingdom neuroscience evidence report: current clinical, research, institution and source-linked intelligence.

Evidence rank #3 of 50 · Data maturity A · Research score 52.2 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.

⚗
452Curated trials
↗
107Recruiting trials
▦
1,645Publications
⌂
731Institutions

Executive interpretation

United Kingdom ranks #3 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.

Methodology status

Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.

Methodology →

Leading sponsors

University College, London245 recruiting
Hoffmann-La Roche225 recruiting
Merck Sharp & Dohme LLC2110 recruiting
University of Oxford195 recruiting
King's College London182 recruiting
University of Nottingham104 recruiting
Novartis Pharmaceuticals92 recruiting
Eli Lilly and Company70 recruiting
Eisai Inc.72 recruiting
Boehringer Ingelheim60 recruiting

Disease activity

Alzheimers77trials
Parkinsons76trials
Epilepsy67trials
Other Neurology29trials
Depression27trials
Neuromuscular20trials
Multiple Sclerosis19trials
Adhd19trials
Stroke19trials
Autism18trials

Research institutions

Genomics EnglandOpenAlexlinked institution
University of SalfordOpenAlexlinked institution
Wythenshawe HospitalOpenAlexlinked institution
World Federation of NeurologyOpenAlexlinked institution
Illumina (United Kingdom)OpenAlexlinked institution
University of West LondonOpenAlexlinked institution
Mental Health FoundationOpenAlexlinked institution
University of WalesOpenAlexlinked institution
International Tennis FederationOpenAlexlinked institution

Clinical evidence trail

NCT07848477PROMOTE: Effects of 5-HT4 Agonism on Cognition and Sleep in Peopl With Low MoodNOT_YET_RECRUITING
NCT07838675MediPD: An Online Mediterranean Diet Program for People Living With Parkinson's DiseaseRECRUITING
NCT07786116The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological ConditionsRECRUITING
NCT07781345A Postmarketing Study of LEQEMBI in United Kingdom (UK) Participants With Alzheimer's Disease (AD)NOT_YET_RECRUITING
NCT07775872Prospective Natural History Study of POLG DiseaseRECRUITING
NCT07771595Study of the Effects of Atomoxetine on MotivationNOT_YET_RECRUITING
NCT07757178Lived Experience Narratives in DementiaRECRUITING
NCT07754981Self-Help Booklets for Sleep in Adults With Pulmonary HypertensionNOT_YET_RECRUITING
NCT07724132An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's DiseaseRECRUITING
NCT07705256EMG-Directed Virtual-Reality Training for Motor Stroke RehabilitationRECRUITING
NCT07498049CFT Guided Self-help Intervention: Parents of Autistic ChildrenNOT_YET_RECRUITING
NCT07440277IIH Intervention: A Clinical Trial Comparing 2 Treatments (Shunts and Stents) Evaluation Of Clinical Effectiveness And Cost EffectivenessRECRUITING

Research evidence trail

PUBMEDMultifunctional theranostic nanocarrier platform for microglia-selective cytochalasin D delivery to modulate neuroinflammation after acute brain injuries.2027-02-01
PUBMEDCannabis use and subsequent onset of manic symptoms and bipolar disorder: A systematic review and meta-analysis.2027-01-01
PUBMEDAnxiety disorders, PTSD, and risk of first-ever stroke: A meta-analysis of 11 million participants.2027-01-01
PUBMEDMultilingual lexical feature analysis of spoken language for predicting major depression symptom severity.2027-01-01
PUBMEDMotor Disorders and Related Conditions in Neuropsychiatry.2026-12-01
PUBMEDLongitudinal magnetic resonance imaging and spectroscopy in a mouse model of cuprizone-induced demyelination.2026-12-01
PUBMEDPsychomotor retardation and risk of Parkinson's disease in unipolar depression: A retrospective cohort study.2026-12-01
PUBMEDSubcutaneous foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's disease (aPD): societal cost impact analysis for the UK, France, Germany, Spain, and Canada.2026-12-01
PUBMEDSpring Military-PTSD: development and pilot evaluation of a guided digital therapy for military veterans with post-traumatic stress disorder (PTSD).2026-12-01
PUBMEDGenetic and environmental origins of the co-occurrence of autistic traits, anxiety and depression: Evidence from meta-analysis and twin study.2026-12-01
PUBMEDVolunteering for Ukraine: scoping the operational experiences and impacts among UK and US veterans.2026-12-01
PUBMEDProgressing the evaluation of managing emotions groups in severe mental illness: feasibility of methodology for an effectiveness randomised controlled trial of scaled up delivery.2026-12-01

World Bank context

IT.NET.USER.ZSinternet_users_pct95.5% · 2024
NY.GDP.MKTP.CDgdp_current_usd$4,002.6B · 2025
NY.GDP.PCAP.CDgdp_per_capita_usd$57,602 · 2025
SE.PRM.ENRRschool_enrollment_primary_pct102.17 · 2023
SE.SEC.ENRRschool_enrollment_secondary_pct112.12 · 2023
SH.XPD.CHEX.GD.ZScurrent_health_expenditure_pct_gdp11.1% · 2024
SH.XPD.CHEX.PC.CDcurrent_health_expenditure_per_capita_usd$5,860 · 2024
SH.XPD.GHED.GD.ZSgovernment_health_expenditure_pct_gdp9.0% · 2023
SP.DYN.CBRT.INbirth_rate_crude9.89 · 2024
SP.POP.TOTLpopulation_total69,487,000 · 2025
SP.URB.TOTL.IN.ZSurban_population_pct83.3% · 2025

Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.

Sources and provenance

ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.

Limitations

Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.